Daniel W Coyne MD
Emeritus Professor, Medicine (Nephrology), Washington University School of Medicine
Join to View Full Profile
4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 314-362-7603
Fax+1 314-747-5213
Dr. Coyne is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Daniel Coyne, MD is a nephrologist based in Saint Louis, MO, with expertise in managing conditions such as hypertension, acute and chronic renal failure, and chronic kidney disease. He completed his residency in Internal Medicine at Emory University School of Medicine and a Fellowship in Nephrology at the Washington University/B-JH/SLCH Consortium. Dr. Coyne, a graduate of the Case Western Reserve University School of Medicine, has an extensive publication record in prominent nephrology journals, with significant contributions in the Clinical Journal of the American Society of Nephrology, Journal of Nephrology, Kidney360, Psychological Medicine, and International Journal of Nephrology and Renovascular Disease. He has also been involved in clinical trials, primarily focused on treatment options for chronic kidney disease.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1987 - 1989
Emory University School of MedicineResidency, Internal Medicine, 1983 - 1986
Case Western Reserve University School of MedicineClass of 1983
Certifications & Licensure
MO State Medical License 1989 - 2027
OH State Medical License 1990 - 1994
GA State Medical License 1984 - 1989
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
National Board of Physicians and Surgeons Internal Medicine- National Board of Physicians and Surgeons Nephrology
Clinical Trials
- The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients Start of enrollment: 2006 Apr 01
- Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) Start of enrollment: 2009 Feb 01
Publications & Presentations
PubMed
- 5 citationsHypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.Jeffrey T Ha, Swapnil Hiremath, Min Jun, Suetonia C Green, David C Wheeler
NEJM Evidence. 2024-09-01 - Iron Repletion for Patients with Heart Failure and Kidney Dysfunction.Daniel W Coyne
Clinical Journal of the American Society of Nephrology. 2023-09-01 - 28 citationsThree Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, N...Daniel W Coyne, Ajay K Singh, Renato D Lopes, Christine K Bailey, Tara L DiMino
Clinical Journal of the American Society of Nephrology. 2022-09-01
Other
- The Value of Intravenous Iron: Beyond the Cave of SpeculationDaniel Coyne, MD, American Society of Nephrology
https://www.doximity.com/articles/b6612a40-619b-4786-9597-ad389c1683b1
UpToDate, Wolters Kluwer Health - 2012-10-24
Press Mentions
Akebia and GSK Will Grapple with Heightened Scrutiny of HIF PHIs After Roxadustat ConcernsAugust 24th, 2021- 1A? No Way. KDOQI Has Lost Its WayMay 14th, 2021
- Pooled Results of Roxadustat Phase 3 StudiesApril 15th, 2021
Grant Support
- Differential Effects Of Doxercalciferol (HECTORAL) And 19-Nor-1,25 DihydroxyNational Center For Research Resources2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
